From: Design, pharmacokinetic profiling, and assessment of kinetic and thermodynamic stability of novel anti-Salmonella typhi imidazole analogues
Ligand
Rule
B-1
B-2
R
Lipinski’s
yes
 HBA
4
5
 HBD
2
3
 MW (gmol−1)
372.8
388.8
331.34
 cLogP(o/w)
2.45
2.04
1.10
Veber’s
Yes
 NRB
7
 TPSA (Å2)
95.9
116.13
74.54